FDA Clears Hydrus Microstent for Glaucoma FDA Clears Hydrus Microstent for Glaucoma
The Hydrus microstent used in conjunction with cataract surgery achieves significant and sustained lowering of intraocular pressure in patients with primary open-angle glaucoma.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 14, 2018 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news

Nuclear medicine duties not always shared equally
What's in a name? Apparently a lot when it comes to nuclear medicine. Physicians...Read more on AuntMinnie.comRelated Reading: Live from SNMMI 2018: Nuclear medicine and patients SNMMI 2018: A year of promotion and ongoing challenges Radiology extenders improve workflow, job satisfaction Study tracks radiation dose to NM technologists Nuclear medicine techs have higher risk of cataracts (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 14, 2018 Category: Radiology Source Type: news

National Ophthalmology Database audit annual report
The Healthcare Quality Improvement Partnership has commissioned the National Ophthalmology Database (NOD) cataract audit to report on all NHS funded cataract surgery in England and Wales. (Source: NHS Networks)
Source: NHS Networks - August 14, 2018 Category: UK Health Source Type: news

Ivantis Now Has Its MIGS Stent Approved
The competition in the microinvasive glaucoma surgical (MIGS) space is certainly heating up after today’s news. FDA has given a nod to Ivantis’ Hydrus Microstent, which will undoubtedly compete against Glaukos’ iStent. Irvine,CA-based Ivantis’ approval comes on the heels of Glaukos winning a nod from FDA for the iStent inject Trabecular Micro-Bypass System. The Hydrus Microstent is used to treat patients with mild to moderate primary open-angle glaucoma in conjunction with cataract surgery. The device’s approval is based on the HORIZO...
Source: MDDI - August 13, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

FDA approves Ivantis ’ Hydrus microstent
Ivantis said today it won FDA approval for its Hydrus microstent designed to treat patients with mild to moderate primary open-angle glaucoma in conjunction with cataract surgery. The Hydrus microstent is designed for minimally invasive microsurgical procedures to reduce eye pressure in patients with glaucoma. The device is multi-modal, the company said, by creating a large opening through the trabecular meshwork and dilating and scaffolding the conventional pathway through which fluid exits the eye. Approval came based on results from the Horizon trial, which the Irvine, Calif.-based company touted as the largest min...
Source: Mass Device - August 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Ivantis Source Type: news

A fight for sight that we all need to join | Letters
Betty Boothroyd, former Speaker of the House of Commons, calls for more research funding for eye healthRe your article on age-related macular degeneration (G2, 16 July), this week the eye research charityFight for Sight is launching a campaign to raise awareness of eye health and the desperate need for more research funding. This is an issue close to my heart. Many people of my age are starting to have difficulty with their sight and over 2 million people in the UK are affected by sight loss – a figure set to double by 2050. The answer lies in research. Breakthroughs have already led to pioneering treatment...
Source: Guardian Unlimited Science - July 24, 2018 Category: Science Authors: Letters Tags: Medical research Society Health Science Source Type: news

Pay £15,000 to jump the queue for a hip operation on the NHS
A Daily Mail investigation uncovered how two-thirds of hospitals allow patients to pay out of their pockets for hip and knee replacements and cataract surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - July 21, 2018 Category: Consumer Health News Source Type: news

Improving Accuracy for IOL Selection in Cataract Surgery Improving Accuracy for IOL Selection in Cataract Surgery
Find out about the recent advances that have led to improved accuracy in intraocular lens selection for cataract surgery.Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2018 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

LensGen updates on Juvene IOL, adds $15m to Series A
Intraocular lens developer LensGen said today it hit clinical performance milestones that triggered the release of $11 million that was part of its Series A financing round, and added that lead investor Hoya opted to invest an additional $4.4 million. The Irvine, Calif.-based company also said it is expanding from its current office location into a 14,000 square foot office and lab space intended to accommodate new employees as the company grows, and to support R&D and manufacturing. “We are pleased that LensGen is continuing to make outstanding progress on its clinical and business development goals. W...
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic lensgen Source Type: news

Cataract Surgery May Cut Risk of Serious Car Accidents
TUESDAY, July 17, 2018 -- Cataract surgery is associated with a modest decrease in the risk of the patient being in a serious traffic crash as the driver, according to a study published online June 28 in JAMA Ophthalmology. Matthew B. Schlenker,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 17, 2018 Category: Pharmaceuticals Source Type: news

Vivior closes unspecified round to support wearable IOL optimizer
Ophthalmic device developer Vivior said today it closed a multi-million dollar private investment round to help support its novel wearable system designed to collect activity from patients. The Zurich, Germany-based company said funds from the round will help support a clinical study exploring the usability of their system, with plans to seek clearance in Europe and the US afterwards. “We will look back in 5 years’ time and wonder how we ever managed to treat patients without objective data,” Dr. Arthur Cumming of the Wellington Eye Clinic said in a press release. Vivior is developing a wearable system de...
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic vivior Source Type: news

A case of drug induced lung injury caused by levofloxacin eye drops - Hosogaya N, Toida K, Ishihara H, Kugiyama K.
A 78 year-old man, who received levofloxacin eye drops as a perioperative prophylactic antibacterial agent for cataract surgery, developed pyrexia and dyspnea, followed by respiratory failure. He was diagnosed as drug-induced lung injury due to levofloxaci... (Source: SafetyLit)
Source: SafetyLit - July 10, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Combined Cataract Surgery Ups Postop Endophthalmitis Risk Combined Cataract Surgery Ups Postop Endophthalmitis Risk
A nationwide database study found increased risk for postoperative endophthalmitis with combined cataract surgery vs standalone cataract surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 5, 2018 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Association of cataract surgery with traffic crashes - Schlenker MB, Thiruchelvam D, Redelmeier DA.
IMPORTANCE: Cataracts are the most common cause of impaired vision worldwide and may increase a driver's risk of a serious traffic crash. The potential benefits of cataract surgery for reducing a patient's subsequent risk of traffic crash are uncertain. ... (Source: SafetyLit)
Source: SafetyLit - July 5, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Cataract Surgery Tied to Lower Risk of Car Crashes Cataract Surgery Tied to Lower Risk of Car Crashes
Drivers with cataracts who get surgery to have them removed may lower their risk of getting into traffic crashes, a recent study suggests.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 2, 2018 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Cataract Surgery Tied to Fewer Car Crashes for Seniors
Title: Cataract Surgery Tied to Fewer Car Crashes for SeniorsCategory: Health NewsCreated: 6/28/2018 12:00:00 AMLast Editorial Review: 6/29/2018 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - June 29, 2018 Category: Opthalmology Source Type: news

Cataract surgery tied to lower risk of car crashes
(Reuters Health) - Drivers with cataracts who get surgery to have them removed may lower their risk of getting into traffic crashes, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - June 28, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Cataract Surgery Tied to Fewer Car Crashes for Seniors
THURSDAY, June 28, 2018 -- Data on more than half a million Canadian seniors shows that traffic accident rates fall after drivers undergo a needed cataract surgery. The effect was relatively modest -- about a 9 percent decline -- but suggest that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 28, 2018 Category: General Medicine Source Type: news

Medical News Today: What is a slit lamp exam?
A slit lamp exam is a routine procedure where a doctor shines a light into the eye to look for injuries or diseases. These may include a detached retina, corneal abrasion, or cataracts. Abnormal results can also indicate infection, inflammation, or increased eye pressure. Learn more about the slit lamp exam here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 26, 2018 Category: Consumer Health News Tags: Eye Health / Blindness Source Type: news

Glaukos wins FDA PMA for iStent inject glaucoma device
Glaukos (NYSE:GKOS) said today it won FDA premarket approval for its iStent inject trabecular micro-bypass system. With the clearance, the iStent inject is now indicated for use in the reduction of intraocular pressure in adults with mild to moderate primary open-angle glaucoma who are undergoing concomitant cataract surgery. San Clemente, Calif.-based Glaukos said the iStent inject is designed to treat mild-to-moderate open-angle glaucoma in patients undergoing cataract surgery. It uses a pair of heparin-coated titanium stents in a pre-loaded auto-injection system that allows them to be injected into multiple trabecu...
Source: Mass Device - June 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Pre-Market Approval (PMA) Regulatory/Compliance Glaukos Source Type: news

Boy, 9, left with an untreatable hole in his eye after playing with a laser pointer
Normally macular holes are treatable, but the surgery inevitably causes cataracts, which permanently clouds vision. However, in this case in Greece, even that wasn't an option. (Source: the Mail online | Health)
Source: the Mail online | Health - June 21, 2018 Category: Consumer Health News Source Type: news

Alcon AcrySof ® IQ PanOptix® trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens (IOL) compared to the ZEISS AT LISA®* tri 839MP IOL. These findings further strengthen the value of the PanOptix IOL ENLIGHTENTM optical technology, to provide enhanced image quality and more comfortable near to intermediate vision setting the AcrySof IQ PanOptix IOL apart from other trifocal IOLs. (Source: World Pharma News)
Source: World Pharma News - June 18, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Congo-Brazzaville:Feature - Chinese Doctors Bring Brightness to Congolese Cataract Patients
[Focac] Brazaville -For 65-year-old Balossa Yvonne, a Congolese woman who is suffering from cataract for months, a cure for her illness is to receive a surgery. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 13, 2018 Category: African Health Source Type: news

The Queen has successful cataract procedure
Buckingham Palace confirms that the Queen had the "short planned procedure" in London last month. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 8, 2018 Category: Consumer Health News Source Type: news

Meet the best cataract surgeons in Britain and learn the treatments used to improve sight  
The Daily Mail has gathered views of more than 260 consultants across seven specialities from around the country and asked them who would they refer and why. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2018 Category: Consumer Health News Source Type: news

Myopia could be linked to longer periods spent in education
Educational practices may need to change to prevent damaged vision Related items fromOnMedica Eye problems: the eyelids Eye problems Eye health care placing avoidable pressure on GPs in London Two thirds of eye units restricting access to cataract surgery Stem cell 'patch' offers hope for macular degeneration (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 7, 2018 Category: UK Health Source Type: news

The UK is heading for 'cataract catastrophe just around the corner'
Writing in his new ebook, eye surgeon David Allamby, from London's Focus Clinic, warned the 'likely outcome' of the crisis is that the patient will suffer. (Source: the Mail online | Health)
Source: the Mail online | Health - June 6, 2018 Category: Consumer Health News Source Type: news

The UK is heading for a 'cataract catastrophe just around the corner'
Writing in his new ebook, eye surgeon David Allamby, from London's Focus Clinic, warned the 'likely outcome' of the crisis is that the patient will suffer. (Source: the Mail online | Health)
Source: the Mail online | Health - June 6, 2018 Category: Consumer Health News Source Type: news

FDA Approves First Artificial Iris
A German company has become the first to score FDA approval for a stand-alone prosthetic iris in the United States. The agency said Wednesday afternoon that it approved the CustomFlex Artificial Iris, made by Erlangen, Germany-based HumanOptics. The device, which is surgically implanted, is approved to treat adults and children whose iris is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye. “Patients with iris defects may experience severe vision problems, as well as dissatisfaction with the appearance of their eye,” said Malvina Eydelman, MD, dire...
Source: MDDI - May 30, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

Cataract surgery and motor vehicle fatality prevention - Desapriya E, Jhauj R, Merchant K.
To the Editor Cataract is the leading cause of vision impairment in older adults in the United States and North America. The recent study by Tseng et al1 found that cataract surgery was associated with a 60% reduced risk of death from all causes and a 3... (Source: SafetyLit)
Source: SafetyLit - May 30, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Cataract surgery and motor vehicle fatality prevention-reply - Tseng VL, Yu F, Coleman AL.
In Reply We thank Desapriya et al for the attentive correspondence to our study. As they note, long wait times for cataract surgery have been shown to be associated with decreased quality of life and increased injuries. As noted in our study, a study t... (Source: SafetyLit)
Source: SafetyLit - May 30, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Tanzania:How Japanese Eye Specialists Will Treat Dar Cataract Patients Without Surgery
[Citizen] Dar es Salaam -Japanese eye specialists will treat cataract patients in Dar es Salaam this week without performing invasive surgery. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 29, 2018 Category: African Health Source Type: news

New mechanism essential for eye lens development identified
(University of Delaware) A team led by a University of Delaware researcher has identified the protein essential for eye lens development and clear vision. Without the protein, eyes will form cataracts; with it, lens cells are cleared and ready to see. The work is providing fundamental new knowledge on the basic underlying mechanisms involved in eye development. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 18, 2018 Category: Cancer & Oncology Source Type: news

Sun's UV Rays a Threat to Your Eyes, Too
FRIDAY, May 11, 2018 -- It's not just your skin that needs protection from ultraviolet rays, health experts warn. UV rays from the sun can cause corneal sunburn (photokeratitis) and UV damage that has been linked to macular degeneration, cataracts,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 11, 2018 Category: General Medicine Source Type: news

Japanese cataract patient has respiratory failure from his eye drops
Doctors in Yamanashi - 79 miles (127km) west of the capital Tokyo - believe it is the first recorded case of a such a reaction. They fear he was allergic to levofloxacin - one of the most widely used drops. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2018 Category: Consumer Health News Source Type: news

Glaucoma Device Makers See a Bright Future Ahead
Were The Graduate's Ben Braddock to receive a one-word bit of career advice today, it might very well be "MIGS" instead of plastics. MIGS stands for minimally invasive glaucoma surgery, and both financial analysts and developers of the tiny devices designed to treat the disease expect the market to pop for the foreseeable future. "On a scale of one through 10, I would say the market is probably somewhere between one and two in terms of maturity," said Dave Van Meter, CEO of Irvine, CA-based Ivantis. "The market in the U.S. today is probably somewhere around a couple hundred million dollars, ac...
Source: MDDI - May 11, 2018 Category: Medical Devices Authors: Greg Goth Tags: Implants Source Type: news

Alcon Cares Project 100 commits to reducing cataract blindness globally
Alcon, the global leader in eye care and a division of Novartis, has announced Alcon Cares Project 100, which aims to reduce cataract blindness by providing equipment to perform phaco surgeries. Alcon Cares, a foundation that oversees equipment and product donations to those in need, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America, and Africa over the next three years, making it one of the largest eye care equipment donations of its kind. (Source: World Pharma News)
Source: World Pharma News - May 10, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Alcon launches project to reduce cataract blindness
Alcon, a division of Novartis, launched its Alcon Cares Project 100 to take steps in reducing cataract blindness globally. The company also plans to donate 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America and Africa over the next three years. Alcon aims to reduce cataract blindness by providing equipment to perform phaco surgeries. The foundation Alcon Cares will oversee equipment and product donations to countries in need. Get the full story on our sister site, Medical Design & Outsourcing. The post Alcon launches project to reduce cataract blindness appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Hospital Care Surgical Alcon cataracts Source Type: news

Chinese IOL maker Wuxi Vision Pro raises $13m in Series B
Chinese intraocular lens maker Wuxi Vision Pro said today it completed a $12.6 million (RMB ¥80 million) Series B round. Investors in the round were Qiming Venture Partners and Ruijian Capital, the Shanghai-based company said. Wuxi Vision Pro develops its own intraocular lens material at a manufacturing facility in Irvine, Calif., and produces the Leiming aspheric intraocular lenses which have won Chinese FDA approval and CE Mark approval in the European Union. “I’m so glad to see Vision Pro Ltd. is growing rapidly. With Leiming aspheric IOLs successfully passing clinical trials and being put into the ...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic wuxivisionpro Source Type: news

An Alarm About Anthem's Proposed Cuts To Anesthesia Staff During Eye Surgery
Anthem ’s guidance if implemented, would increase the risk of complications during routine cataract surgery (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2018 Category: Pharmaceuticals Authors: Elaine Schattner, Contributor Tags: NYSE:ANTM Source Type: news

Lens-power Calculations for Young Kids With Cataracts May Be Off Lens-power Calculations for Young Kids With Cataracts May Be Off
In cataract surgery for young children, intraocular-lens power calculations may introduce error and overcorrection, a study from South Korea suggests.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 24, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Report: Johnson & Johnson sees Vision Care biz grow, looks to expand beyond contacts
Johnson & Johnson (NYSE:JNJ) saw its vision care sales grow 34% last quarter over its previous first quarter as it looks to significantly grow the business into the surgical and device segments, according to a CNBC report. The company added a number of surgical products alongside a contact subscription service, which come in addition to its existing popular Acuvue contact lens line, according to the report. The investment has seen a significant return for the company, becoming one of its fastest-growing platforms. Johnson & Johnson only began investing in eye surgery two years ago after announcing it would acq...
Source: Mass Device - April 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Wall Street Beat johnsonandjohnson Source Type: news

Nigeria:Delta State Has Over 40,000 Blind People
[Guardian] Asaba -Delta State has over 40,000 blind people, while 20,000, mostly women and children, are infected with cataract. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 22, 2018 Category: African Health Source Type: news

Sonographers exposed to radiation from MPI patients
A new study found that sonographers who performed cardiac ultrasound studies...Read more on AuntMinnie.comRelated Reading: SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET SNMMI to watch for job-related health problems Nuclear medicine techs have higher risk of cataracts CZT-based SPECT MPI may predict cardiac outcomes Cardiac cath radiation exacts toll on health personnel (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2018 Category: Radiology Source Type: news

Ivantis touts 1-year head-to-head Hydrus, iStent study data
This study looks at the viability of MIGS in patients who don’t need or may have already had cataract surgery, so it’s a vital addition to our growing body of evidence supporting MIGS,” Compare trial medical monitor Dr. Iqbal Ahmed said in a prepared release. Ivantis said the 152-patient trial was the first to compare two minimally invasive glaucoma surgery device for treating open-angle glaucoma in a standalone procedure. The study aimed to compare safety and effectiveness of both devices in lowering IOP and reducing eye-drop medication. Results at one year showed that 47% of eyes treated with the Hydrus...
Source: Mass Device - April 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Glaukos Ivantis Source Type: news

Glaukos touts 2-year iStent inject pivotal trial data, levies infringement suit against Ivantis
Glaukos (NYSE:GKOS) today released two-year data from the FDA investigational device exemption pivotal trial of its iStent inject trabecular micro-bypass system, and announced a patent infringement suit it filed against Ivantis. Results of the 505-patient study were presented at the American Society of Cataracts and Refractive Surgery annual meeting by Dr. Thomas Samuelson of the Minnesota Eye Consultants, the San Clemente, Calif.-based company said. The iStent inject trabecular micro-bypass system is designed to treat mild-to-moderate open-angle glaucoma in patients undergoing cataract surgery. It uses a pa...
Source: Mass Device - April 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Patent Infringement Glaukos Source Type: news

Cataract Surgery on Ebola Survivors Safe for Docs
WEDNESDAY, April 11, 2018 -- Doctors needn't worry when they perform cataract surgery on Ebola survivors with eye problems caused by the highly contagious virus, a new study finds. Between 13 percent and 34 percent of Ebola survivors develop eye... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 11, 2018 Category: General Medicine Source Type: news

Solid Outcomes for Femtosecond Laser Cataract Surgery Solid Outcomes for Femtosecond Laser Cataract Surgery
A new study shows the benefit of femtosecond laser-assisted cataract surgery.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2018 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Post-Ebola cataract surgery can safely restore vision
(Emory Health Sciences) Cataract surgery can be safely performed on Ebola virus disease survivors with impaired vision, Emory Eye Center ophthalmologists and 40 colleagues around the world report. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 4, 2018 Category: International Medicine & Public Health Source Type: news

Anthem Policy on Cataract Surgery Stirs Debate: HealthLeaders Media
(MedPage Today) -- Also, clinicians voice concerns about Anthem anesthesia policy (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 26, 2018 Category: Primary Care Source Type: news